Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
Ultima descărcare din IBN: 2023-08-01 14:53 |
Căutarea după subiecte similare conform CZU |
616-006.6-085:577.21:615.277 (1) |
Патология. Клиническая медицина (7212) |
Материальные основы жизни. Биохимия. Молекулярная биология. Биофизика (671) |
Лекарственные средства в соответствии с их активным веществом (398) |
![]() BULAT, Iurie, BULAT, Ana-Maria. Congresul ASCO 2019 – posibilități contemporane ale tratamentului medical personalizat al tumorilor maligne.. In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2019, nr. 4(64), pp. 8-17. ISSN 1857-0011. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale | ||||||
Numărul 4(64) / 2019 / ISSN 1857-0011 | ||||||
|
||||||
CZU: 616-006.6-085:577.21:615.277 | ||||||
Pag. 8-17 | ||||||
|
||||||
![]() |
||||||
Rezumat | ||||||
Acest reviu include analiza unor rezultate impresionante a eficacității terapiilor contemporane la pacienți cu cancere pulmonare, cancere ale regiunii capului și gâtului, cancer mamar, cancer gastric, tumori cerebrale primare și melanom malign, care au fost prezentate la Congresul ASCO 2019. |
||||||
Cuvinte-cheie inhibitori ai punctelor de control imun, inhibitori tirozinkinazici, marcheri molecular-genetici, immune checkpoint inhibitors, thyrosine kinase inhibitors, molecular-genetic markers, ингибиторы контрольных иммунных точек, тирозинкиназные ингибиторы, молекулярно-генетические маркеры |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-115165</cfResPublId> <cfResPublDate>2019-12-27</cfResPublDate> <cfVol>64</cfVol> <cfIssue>4</cfIssue> <cfStartPage>8</cfStartPage> <cfISSN>1857-0011</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/115165</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Congresul ASCO 2019 – posibilități contemporane ale tratamentului medical personalizat al tumorilor maligne.</cfTitle> <cfKeyw cfLangCode='RO' cfTrans='o'>inhibitori ai punctelor de control imun; inhibitori tirozinkinazici; marcheri molecular-genetici; immune checkpoint inhibitors; thyrosine kinase inhibitors; molecular-genetic markers; ингибиторы контрольных иммунных точек; тирозинкиназные ингибиторы; молекулярно-генетические маркеры</cfKeyw> <cfAbstr cfLangCode='RO' cfTrans='o'><p>Acest reviu include analiza unor rezultate impresionante a eficacității terapiilor contemporane la pacienți cu cancere pulmonare, cancere ale regiunii capului și gâtului, cancer mamar, cancer gastric, tumori cerebrale primare și melanom malign, care au fost prezentate la Congresul ASCO 2019.</p></cfAbstr> <cfAbstr cfLangCode='EN' cfTrans='o'><p>This review includes the analysis of impressive results of efficacy of contemporary therapies in patients with lung cancer, cancer of the head and neck, breast cancer, gastric cancer, primary cerebral tumors and malignant melanoma, which were presented at the ASCO 2019 Congress</p></cfAbstr> <cfAbstr cfLangCode='RU' cfTrans='o'><p>Данный обзор содержит анализ впечатляющих результатов по эффективности современных терапий в лечении пациентов с злокачественными опухолями легких, области головы и шеи, раком молочной железы, раком желудка, первичными опухолями мозга и меланомой, которые были доложены на Конгрессе ASCO 2019.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-12-27T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2019-12-27T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-11681</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-12-27T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-82911</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2019-12-27T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-11681</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11681-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-12-27T24:00:00</cfStartDate> <cfFamilyNames>Булат</cfFamilyNames> <cfFirstNames>Ю.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-82911</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-82911-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2019-12-27T24:00:00</cfStartDate> <cfFamilyNames>Bulat</cfFamilyNames> <cfFirstNames>Ana-Maria</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>